Subtopic Deep Dive
Tissue Transglutaminase Autoimmunity
Research Guide
What is Tissue Transglutaminase Autoimmunity?
Tissue transglutaminase autoimmunity refers to the immune response targeting tissue transglutaminase (tTG) as the primary autoantigen in celiac disease, triggered by deamidation of gluten peptides.
tTG deamidates glutamine residues in gliadin peptides, enhancing their binding to HLA-DQ2/DQ8 molecules and initiating CD4+ T cell responses (Dieterich et al., 1997; 2043 citations). Anti-tTG antibodies serve as key diagnostic markers with high sensitivity (Sulkanen et al., 1998; 607 citations). Over 10 foundational papers since 1997 define this mechanism, with 15,000+ total citations.
Why It Matters
tTG autoimmunity explains gluten-triggered intestinal damage in celiac disease, enabling serologic tests like anti-tTG ELISA that diagnose 90-95% of cases before biopsy (Sulkanen et al., 1998). Structural insights into tTG-deamidated gliadin complexes guide epitope-specific therapies (Shan et al., 2002; 1559 citations). Oslo definitions standardize terminology for clinical trials targeting immune tolerance (Ludvigsson et al., 2012; 1657 citations), while BSG guidelines integrate tTG assays into management protocols (Ludvigsson et al., 2014; 1080 citations).
Key Research Challenges
Epitope Specificity Mapping
Identifying immunodominant deamidated gliadin epitopes targeted by tTG remains incomplete due to peptide complexity. Arentz-Hansen et al. (2000; 654 citations) focused on a single glutamine, but broader mapping needs mass spectrometry advances. This limits vaccine design.
Diagnostic False Negatives
Anti-tTG assays miss 5-10% of celiac cases, especially IgA-deficient patients. Sulkanen et al. (1998; 607 citations) validated ELISA sensitivity, yet guidelines highlight variability (Ludvigsson et al., 2014). Combining with EMA improves accuracy.
Therapeutic Immune Modulation
Blocking tTG activity or gliadin presentation fails in trials due to redundant pathways. Schuppan (2000; 544 citations) outlined pathogenesis gaps; recent models require HLA-peptide-tTG crystallography (Shan et al., 2002).
Essential Papers
Identification of tissue transglutaminase as the autoantigen of celiac disease
Walburga Dieterich, Tobias Ehnis, Michael Bauer et al. · 1997 · Nature Medicine · 2.0K citations
The Oslo definitions for coeliac disease and related terms
Jonas F. Ludvigsson, Daniel A. Leffler, Julio C. Bai et al. · 2012 · Gut · 1.7K citations
This paper presents the Oslo definitions for CD-related terms.
Structural Basis for Gluten Intolerance in Celiac Sprue
Lu Shan, Øyvind Molberg, Isabelle Parrot et al. · 2002 · Science · 1.6K citations
Celiac Sprue, a widely prevalent autoimmune disease of the small intestine, is induced in genetically susceptible individuals by exposure to dietary gluten. A 33-mer peptide was identified that has...
Wheat
Peter R. Shewry · 2009 · Journal of Experimental Botany · 1.2K citations
Wheat is the dominant crop in temperate countries being used for human food and livestock feed. Its success depends partly on its adaptability and high yield potential but also on the gluten protei...
Spectrum of gluten-related disorders: consensus on new nomenclature and classification
Anna Sapone, Julio C. Bai, Carolina Ciacci et al. · 2012 · BMC Medicine · 1.1K citations
Abstract A decade ago celiac disease was considered extremely rare outside Europe and, therefore, was almost completely ignored by health care professionals. In only 10 years, key milestones have m...
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology
Jonas F. Ludvigsson, Julio C. Bai, Federico Biagi et al. · 2014 · Gut · 1.1K citations
A multidisciplinary panel of 18 physicians and 3 non-physicians from eight countries (Sweden, UK, Argentina, Australia, Italy, Finland, Norway and the USA) reviewed the literature on diagnosis and ...
The Intestinal T Cell Response to α-Gliadin in Adult Celiac Disease Is Focused on a Single Deamidated Glutamine Targeted by Tissue Transglutaminase
Helene Arentz–Hansen, Roman Körner, Øyvind Molberg et al. · 2000 · The Journal of Experimental Medicine · 654 citations
The great majority of patients that are intolerant of wheat gluten protein due to celiac disease (CD) are human histocompatibility leukocyte antigen (HLA)-DQ2+, and the remaining few normally expre...
Reading Guide
Foundational Papers
Start with Dieterich et al. (1997; 2043 citations) for tTG autoantigen discovery, then Shan et al. (2002; 1559 citations) for structural mechanisms, followed by Arentz-Hansen et al. (2000; 654 citations) for T cell epitopes.
Recent Advances
Ludvigsson et al. (2014; 1080 citations) for BSG diagnostic guidelines; Sapone et al. (2012; 1128 citations) for gluten disorder spectrum including tTG roles.
Core Methods
Deamidation assays via tTG enzyme kinetics (Dieterich 1997); peptide MHC binding (Shan 2002); anti-tTG ELISA (Sulkanen 1998); mass spec for epitopes (Arentz-Hansen 2000).
How PapersFlow Helps You Research Tissue Transglutaminase Autoimmunity
Discover & Search
Research Agent uses searchPapers('tissue transglutaminase autoantigen celiac') to retrieve Dieterich et al. (1997; 2043 citations), then citationGraph reveals 500+ downstream papers on deamidation, while findSimilarPapers expands to Shan et al. (2002) for structural analogs and exaSearch uncovers 2023 reviews on tTG inhibitors.
Analyze & Verify
Analysis Agent applies readPaperContent on Dieterich et al. (1997) to extract deamidation mechanisms, verifies claims via verifyResponse (CoVe) against Sulkanen et al. (1998) ELISA data, and runs PythonAnalysis to plot antibody sensitivity (95% via NumPy/pandas on abstract metrics) with GRADE scoring evidence as high-quality.
Synthesize & Write
Synthesis Agent detects gaps in tTG therapy trials via contradiction flagging across Schuppan (2000) and Ludvigsson (2014), while Writing Agent uses latexEditText for review drafts, latexSyncCitations to link 20 papers, latexCompile for PDF, and exportMermaid diagrams HLA-DQ2-gliadin-tTG complexes.
Use Cases
"Plot anti-tTG antibody sensitivity vs specificity from celiac diagnostic studies."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on Sulkanen 1998 + 5 papers data) → ROC curve plot + GRADE B evidence.
"Draft LaTeX review on tTG deamidation epitopes with citations."
Research Agent → citationGraph (Arentz-Hansen 2000) → Synthesis → gap detection → Writing Agent → latexEditText + latexSyncCitations (10 papers) → latexCompile → PDF export.
"Find code for simulating tTG-gliadin deamidation kinetics."
Research Agent → paperExtractUrls (Shan 2002 supplements) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python sandbox validation.
Automated Workflows
Deep Research workflow scans 50+ tTG papers via searchPapers → citationGraph → structured report on autoimmunity progression (Dieterich 1997 baseline). DeepScan applies 7-step CoVe to verify deamidation claims in Arentz-Hansen (2000) against Shan (2002) structures. Theorizer generates hypotheses on tTG inhibition from Schuppan (2000) pathogenesis gaps.
Frequently Asked Questions
What defines tissue transglutaminase autoimmunity?
It is the targeting of tTG by autoantibodies after deamidating gliadin glutamines, creating HLA-DQ2/8 epitopes (Dieterich et al., 1997).
What are key methods for studying tTG autoimmunity?
Mass spectrometry maps deamidated peptides (Arentz-Hansen et al., 2000); ELISA quantifies anti-tTG IgA (Sulkanen et al., 1998); crystallography reveals structures (Shan et al., 2002).
What are seminal papers?
Dieterich et al. (1997; 2043 citations) identified tTG as autoantigen; Shan et al. (2002; 1559 citations) showed gliadin-tTG basis; Ludvigsson et al. (2012; 1657 citations) defined terms.
What open problems exist?
Developing tTG inhibitors for therapy; reducing diagnostic false negatives; mapping full epitope repertoires beyond single glutamines (Schuppan, 2000).
Research Celiac Disease Research and Management with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Tissue Transglutaminase Autoimmunity with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers